Paul Tudor Jones’s Array Biopharma Inc ARRY Stock Holding History

Paul Tudor Jones’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-371,306	Closed	-$17.2M	–	1467
2019 Q2	$17.2M	Buy	+371,306	New	+$10.4M	0.49%	19
2018 Q3	–	Sell	-41,310	Closed	-$693K	–	1353
2018 Q2	$693K	Sell	41,310 -34,997	-46%	-$557K	0.02%	567
2018 Q1	$1.25M	Buy	76,307 +63,473	+495%	+$1.02M	0.04%	267
2017 Q4	$164K	Sell	12,834 -62,350	-83%	-$709K	﹤0.01%	988
2017 Q3	$925K	Buy	75,184 +1,811	+2%	+$16.8K	0.02%	421
2017 Q2	$614K	Buy	+73,373	New	+$600K	0.02%	502
2016 Q4	–	Sell	-135,000	Closed	-$911K	–	1724
2016 Q3	$911K	Buy	+135,000	New	+$522K	0.02%	444
2016 Q1	–	Sell	-107,347	Closed	-$453K	–	2076
2015 Q4	$453K	Buy	107,347 +95,847	+833%	+$437K	0.01%	962
2015 Q3	$52K	Buy	+11,500	New	+$68.2K	﹤0.01%	1475

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Paul Tudor Jones's ARRY Position: Q3 2019 in Review

Paul Tudor Jones sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 371,306 shares — an estimated $17.2M sold.

Paul Tudor Jones first reported a position in ARRY in Q3 2015 and held it in 9 quarters. The position peaked at $17.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Paul Tudor Jones reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Paul Tudor Jones sold 371,306 Array Biopharma Inc shares in Q3 2019, an estimated $17.2M.
Paul Tudor Jones first reported a position in Array Biopharma Inc in Q3 2015 and held it in 9 quarters.
Paul Tudor Jones's Array Biopharma Inc position peaked at $17.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Tudor Investment Corp's 13F filing for Q3 2019, filed 14 Nov 2019.